These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24256238)

  • 21. Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system.
    Elmore JR; Sheppard NF; Ramia N; Deighan T; Li H; Terns RM; Terns MP
    Genes Dev; 2016 Feb; 30(4):447-59. PubMed ID: 26848045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression.
    Wiegand T; Karambelkar S; Bondy-Denomy J; Wiedenheft B
    Annu Rev Microbiol; 2020 Sep; 74():21-37. PubMed ID: 32503371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
    Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
    RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR adaptation in Escherichia coli subtypeI-E system.
    Kiro R; Goren MG; Yosef I; Qimron U
    Biochem Soc Trans; 2013 Dec; 41(6):1412-5. PubMed ID: 24256229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The roles of CRISPR-Cas systems in adaptive immunity and beyond.
    Barrangou R
    Curr Opin Immunol; 2015 Feb; 32():36-41. PubMed ID: 25574773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex.
    Zhu X; Ye K
    Nucleic Acids Res; 2015 Jan; 43(2):1257-67. PubMed ID: 25541196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6.
    Niewoehner O; Jinek M
    RNA; 2016 Mar; 22(3):318-29. PubMed ID: 26763118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. To acquire or resist: the complex biological effects of CRISPR-Cas systems.
    Bondy-Denomy J; Davidson AR
    Trends Microbiol; 2014 Apr; 22(4):218-25. PubMed ID: 24582529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes.
    Al-Attar S; Westra ER; van der Oost J; Brouns SJ
    Biol Chem; 2011 Apr; 392(4):277-89. PubMed ID: 21294681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insights into the inactivation of CRISPR-Cas systems by diverse anti-CRISPR proteins.
    Zhu Y; Zhang F; Huang Z
    BMC Biol; 2018 Mar; 16(1):32. PubMed ID: 29554913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The host-encoded RNase E endonuclease as the crRNA maturation enzyme in a CRISPR-Cas subtype III-Bv system.
    Behler J; Sharma K; Reimann V; Wilde A; Urlaub H; Hess WR
    Nat Microbiol; 2018 Mar; 3(3):367-377. PubMed ID: 29403013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Editing and investigating genomes with TALE and CRISPR/Cas systems: applications of artificial TALE and CRISPR-Cas systems.
    Giovannangeli C; Concordet JP
    Methods; 2014 Sep; 69(2):119-20. PubMed ID: 25248487
    [No Abstract]   [Full Text] [Related]  

  • 33. Cas6 processes tight and relaxed repeat RNA via multiple mechanisms: A hypothesis.
    Sefcikova J; Roth M; Yu G; Li H
    Bioessays; 2017 Jun; 39(6):. PubMed ID: 28493337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structures and mechanisms of CRISPR RNA-guided effector nucleases.
    Nishimasu H; Nureki O
    Curr Opin Struct Biol; 2017 Apr; 43():68-78. PubMed ID: 27912110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ring of confidence: a haloarchaeal CRISPR/Cas system.
    Maier LK; Stoll B; Brendel J; Fischer S; Pfeiffer F; Dyall-Smith M; Marchfelder A
    Biochem Soc Trans; 2013 Feb; 41(1):374-8. PubMed ID: 23356314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular dynamic simulations of protein/RNA complexes: CRISPR/Csy4 endoribonuclease.
    Estarellas C; Otyepka M; Koča J; Banáš P; Krepl M; Šponer J
    Biochim Biophys Acta; 2015 May; 1850(5):1072-1090. PubMed ID: 25450173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions.
    Wiedenheft B; van Duijn E; Bultema JB; Waghmare SP; Zhou K; Barendregt A; Westphal W; Heck AJ; Boekema EJ; Dickman MJ; Doudna JA
    Proc Natl Acad Sci U S A; 2011 Jun; 108(25):10092-7. PubMed ID: 21536913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of CRISPR/cas system in the development of bacteriophage resistance.
    Szczepankowska A
    Adv Virus Res; 2012; 82():289-338. PubMed ID: 22420856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress of genome engineering technology via clustered regularly interspaced short palindromic repeats--a review].
    Li H; Qiu S; Song H
    Wei Sheng Wu Xue Bao; 2013 Oct; 53(10):1025-30. PubMed ID: 24409757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.